查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829387

2025年全球子宮肌瘤栓塞裝置市場報告

Uterine Fibroid Embolization Device Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，子宮肌瘤栓塞器械市場規模穩定成長，從2024年的56.2億美元增加到2025年的58.9億美元，複合年成長率為4.7%。這段歷史時期的成長可歸因於子宮肌瘤發病率的上升、對非手術治療方案的偏好、認知和教育舉措、對女性健康的關注、向門診手術的轉變以及醫生培訓計畫的開展。

子宮肌瘤栓塞器械市場規模預計將在未來幾年穩步成長，到2029年將達到69.6億美元，複合年成長率為4.3%。預測期內的成長可歸因於人們對非侵入性治療的認知不斷提高、醫療服務的全球擴張、對女性醫療保健的日益關注、與多學科護理的整合以及門診服務的擴展。預測期內的主要趨勢包括微創治療的普及、栓塞劑的進步、個人化治療方法、對門診UFE治療的關注、影像技術的整合以及對生物可吸收栓塞劑的研究。

子宮肌瘤栓塞裝置是醫療設備。子宮肌瘤是子宮內形成的良性腫瘤，裝置可以限制肌瘤的血液供應，使其縮小並最終消失。

子宮肌瘤栓塞的主要技術包括手術、腹腔鏡手術、切除和栓塞技術。手術技術是指醫護人員採用的特定方法和程序。這些設備可用於多種治療模式，包括侵入性、微創性和非侵入性治療。此外，它們也應用於各種醫療機構，包括醫院、診所和門診手術中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供子宮肌瘤栓塞治療設備的市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的子宮肌瘤栓塞治療設備市場佔有率、詳細的子宮肌瘤栓塞治療設備細分市場、市場趨勢和商機，以及您在子宮肌瘤栓塞治療設備行業取得成功所需的數據。本子宮肌瘤栓塞治療設備市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年4.3%的預測成長率，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這項影響將直接影響美國，導致來自比利時和英國等主要地區的校準栓塞顆粒和微導管輸送系統的供應鏈中斷，可能導致子宮肌瘤患者的治療延誤。此外，由於貿易緊張局勢加劇和限制措施加劇，互惠關稅以及對全球經濟和貿易的負面影響將對全球經濟和貿易產生更廣泛的負面影響。

微創手術需求的不斷成長預計將推動子宮肌瘤栓塞器械市場的成長。微創手術利用小切口或自然體孔進入並治療內臟器官、組織和結構，同時最大限度地減少對患者身體的創傷。子宮肌瘤栓塞器械在這些手術中發揮關鍵作用，它能夠透過微創手術有效治療子宮肌瘤。這些專用器械設計用於小切口，減少對周圍組織的影響，滿足了人們對微創醫療日益成長的偏好，最終改善了患者的治療效果。例如，2023年8月，美國整形外科和美容醫學協會－美學協會(Aesthetic Society)報告稱，美國在整容手術上的支出超過118億美元，年增2%。因此，微創手術需求的不斷成長正在推動子宮肌瘤栓塞器械市場的擴張。

人口老化也有望推動子宮肌瘤栓塞術市場的擴張。在65歲及以上人口的老化社會中，子宮肌瘤栓塞術作為一種微創手術治療方法正日益受到關注。這類患者可以透過這些設備緩解過度出血和骨盆腔疼痛等症狀。根據世界衛生組織（WHO）2022年10月的報告，預計全球60歲以上人口將在2022年達到14億，到2050年將加倍，達到21億。因此，人口老化是子宮肌瘤栓塞術市場發展的驅動力。

子宮肌瘤栓塞器械市場由提供微創手術、非侵入性手術、微創手術、射頻消融術、藥物治療、荷爾蒙療法和栓塞手術等服務的營業單位所獲得的收益組成。市場價值包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。子宮肌瘤栓塞器械市場還包括藥物、子子宮鏡器械、腹腔鏡器械、射頻消融器械、子宮內膜消融器械、子宮切除器械和機器人手術系統的銷售。該市場的價值是“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球子宮肌瘤栓塞設備：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球子宮肌瘤栓塞設備市場：成長率分析
  • 全球子宮肌瘤栓塞設備市場表現：規模與成長，2019-2024
  • 全球子宮肌瘤栓塞設備市場預測：規模與成長，2024-2029年，2034年
  • 全球子宮肌瘤栓塞設備：總目標市場（TAM）

第6章 市場細分

  • 全球子宮肌瘤栓塞設備市場：依技術、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 手術技術
  • 腹腔鏡手術
  • 消融技術
  • 栓塞治療
  • 全球子宮肌瘤栓塞設備市場（依治療方法、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 侵入性治療
  • 微創治療
  • 非侵入性治療
  • 全球子宮肌瘤栓塞設備市場：依最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 門診手術中心
  • 全球子宮肌瘤栓塞設備市場：依手術類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 開放性手術
  • 子宮肌瘤切除術
  • 全球子宮肌瘤栓塞設備市場：依腹腔鏡手術類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 腹腔鏡子宮肌瘤切除術
  • 腹腔鏡子宮切除術
  • 全球子宮肌瘤栓塞設備市場：依消融技術（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 射頻消融
  • 微波消融
  • 冷凍療法
  • 全球子宮肌瘤栓塞設備市場：依栓塞類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 經導管動脈栓塞術（TAE）
  • 子宮動脈栓塞術（UAE）

第7章 區域和國家分析

  • 全球子宮肌瘤栓塞設備市場：區域分析、預測與趨勢（2019-2024 年、2024-2029 年及 2034 年）
  • 全球子宮肌瘤栓塞設備市場：依國家/地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 子宮肌瘤栓塞裝置市場：競爭格局
  • 子宮肌瘤栓塞設備市場：公司簡介
    • Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Stryker Corporation
  • Boston Scientific Corporation
  • GE HealthCare Technologies Inc.
  • Olympus Corporation
  • Terumo Corporation
  • Smith and Nephew plc.
  • Ethicon Inc.
  • Hologic Inc.
  • CooperSurgical Inc.
  • Ferring BV
  • Cook Medical Inc.
  • Karl Storz GmbH
  • Merit Medical Systems
  • CONMED Corporation
  • Amsino International Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 子宮肌瘤栓塞設備市場 2029：提供新機會的國家
  • 子宮肌瘤栓塞設備市場 2029：細分市場帶來新機會
  • 子宮肌瘤栓塞設備市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29208u

A uterine fibroid embolization device is a medical device used in the treatment of noncancerous tumors, specifically uterine fibroids, through a minimally invasive procedure. Uterine fibroids are benign growths in the uterus, and this device functions by restricting the blood supply to these fibroids, causing them to shrink and ultimately disappear.

The main types of technologies associated with uterine fibroid embolization devices include surgical techniques, laparoscopic techniques, ablation techniques, and embolization techniques. Surgical techniques involve specific methods and procedures employed by medical professionals. These devices are utilized in various treatment modes, including invasive, minimally invasive, and non-invasive treatments. Additionally, they find application in diverse healthcare settings such as hospitals, clinics, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The uterine fibroid embolization device market research report is one of a series of new reports from The Business Research Company that provides uterine fibroid embolization device market statistics, including uterine fibroid embolization device industry global market size, regional shares, competitors with a uterine fibroid embolization device market share, detailed uterine fibroid embolization device market segments, market trends and opportunities, and any further data you may need to thrive in the uterine fibroid embolization device industry. This uterine fibroid embolization device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The uterine fibroid embolization device market size has grown steadily in recent years. It will grow from $5.62 billion in 2024 to $5.89 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to increasing incidence of uterine fibroids, preference for non-surgical alternatives, awareness and education initiatives, focus on women's health, shift towards outpatient procedures, physician training programs.

The uterine fibroid embolization device market size is expected to see steady growth in the next few years. It will grow to $6.96 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing awareness of non-invasive treatments, global expansion of healthcare services, rise in female healthcare initiatives, integration with multidisciplinary care, expansion of outpatient services. Major trends in the forecast period include increasing adoption of minimally invasive procedures, advancements in embolic agents, personalized treatment approaches, focus on outpatient ufe procedures, integration of imaging technologies, research on bioresorbable embolic agents.

The forecast of 4.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for calibrated embolic particles and microcatheter delivery systems, sourced from key regions such as Belgium and the United Kingdom, could lead to treatment delays for fibroid patients.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for minimally invasive surgeries is expected to drive the growth of the uterine fibroid embolization device market. Minimally invasive surgeries involve using small incisions or natural body openings to access and treat internal organs, tissues, or structures, minimizing trauma to the patient's body. Uterine fibroid embolization devices play a crucial role in these procedures by effectively treating uterine fibroids while keeping invasiveness to a minimum. These specialized devices are designed to use small incisions, reducing the impact on surrounding tissues, and catering to the rising preference for less invasive medical treatments, ultimately improving patient outcomes. For example, in August 2023, The Aesthetic Society, a US-based organization in plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, marking a 2% increase from the previous year. Thus, the growing demand for minimally invasive surgeries is driving the expansion of the uterine fibroid embolization device market.

The growing aging population is also expected to contribute to the expansion of the uterine fibroid embolization devices market. The aging population, representing individuals aged 65 years and older, benefits from uterine fibroid embolization devices as a minimally invasive alternative to surgery for addressing symptomatic fibroids. This demographic experiences relief from symptoms such as excessive bleeding and pelvic pain through these devices. According to the World Health Organization's October 2022 report, the global population aged 60 years and older reached 1.4 billion in 2022, and by 2050, it is projected to double to 2.1 billion. Therefore, the increasing aging population acts as a driver for the uterine fibroid embolization devices market.

Major companies in the uterine fibroid embolization device market are focusing on developing innovative products such as the TruClear system to address the growing demand for minimally invasive treatments for uterine fibroids, aiming to enhance safety and efficacy. The TruClear system, launched by Medtronic Private Limited in November 2022, is a mechanical hysteroscopic tissue removal system used for treating intrauterine abnormalities. It features a flexible catheter inserted through the cervix into the uterus, incorporating a spinning nitinol wire loop, continuous inflow and outflow, integrated suction, and high-definition imaging, contributing to the precision and safety of uterine fibroid treatment.

In October 2024, Hologic Inc., a US-based medical technology company, acquired Gynesonics for $350 million. Through this acquisition, Hologic seeks to expand its range of minimally invasive treatment options for women's health, with a focus on managing uterine fibroids and heavy menstrual bleeding. Gynesonics Inc. is a US-based medical technology company specializing in the development of minimally invasive solutions for treating symptomatic uterine fibroids.

Major companies operating in the uterine fibroid embolization device market report are Johnson and Johnson Pvt Ltd., Abbott Laboratories, Medtronic plc., Siemens Healthineers Ltd., Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, GE HealthCare Technologies Inc., Olympus Corporation, Terumo Corporation, Smith and Nephew plc., Ethicon Inc., Hologic Inc., CooperSurgical Inc., Ferring B.V., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Amsino International Inc., Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., INSIGHTEC Ltd., Hironic Co.Ltd., Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC, Hitachi Medical Corporation

North America was the largest region in the uterine fibroid embolization device market in 2024. The regions covered in the uterine fibroid embolization device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the uterine fibroid embolization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The uterine fibroid embolization device market consists of revenues earned by entities by provide services such as minimally invasive procedures, non-invasive procedures, minimally invasive procedures, radiofrequency ablation, medication and hormonal therapy, and embolization procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The uterine fibroid embolization device market also includes sales of medications, hysteroscopic devices, laparoscopic devices, radiofrequency ablation devices, endometrial ablation devices, hysterectomy devices, and robotic surgical systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uterine Fibroid Embolization Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on uterine fibroid embolization device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for uterine fibroid embolization device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The uterine fibroid embolization device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Surgical Techniques; Laparoscopic Techniques; Ablation Techniques; Embolization Techniques
  • 2) By Mode Of Treatment: Invasive Treatment; Minimally Invasive Treatment; Non-Invasive Treatment
  • 3) By End User: Hospitals; Clinics; Ambulatory Surgical Center
  • Subsegments:
  • 1) By Surgical Techniques: Open Surgery; Myomectomy
  • 2) By Laparoscopic Techniques: Laparoscopic Myomectomy; Laparoscopic Hysterectomy
  • 3) By Ablation Techniques: Radiofrequency Ablation; Microwave Ablation; Cryoablation
  • 4) By Embolization Techniques: Transcatheter Arterial Embolization (TAE); Uterine Artery Embolization (UAE)
  • Companies Mentioned: Johnson and Johnson Pvt Ltd.; Abbott Laboratories; Medtronic plc.; Siemens Healthineers Ltd.; Koninklijke Philips N.V.; Stryker Corporation; Boston Scientific Corporation; GE HealthCare Technologies Inc.; Olympus Corporation; Terumo Corporation; Smith and Nephew plc.; Ethicon Inc.; Hologic Inc.; CooperSurgical Inc.; Ferring B.V.; Cook Medical Inc.; Karl Storz GmbH; Merit Medical Systems; CONMED Corporation; Amsino International Inc.; Lumenis Ltd.; Richard Wolf GmbH; BTG International Ltd.; Healthium MedTech Pvt. Ltd.; INSIGHTEC Ltd.; Hironic Co.Ltd; Minerva Surgical Inc.; Gynesonics Inc.; Advanced Surgical Concepts PLLC; Hitachi Medical Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Uterine Fibroid Embolization Device Market Characteristics

3. Uterine Fibroid Embolization Device Market Trends And Strategies

4. Uterine Fibroid Embolization Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Uterine Fibroid Embolization Device Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Uterine Fibroid Embolization Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Uterine Fibroid Embolization Device Market Growth Rate Analysis
  • 5.4. Global Uterine Fibroid Embolization Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Uterine Fibroid Embolization Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Uterine Fibroid Embolization Device Total Addressable Market (TAM)

6. Uterine Fibroid Embolization Device Market Segmentation

  • 6.1. Global Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Techniques
  • Laparoscopic Techniques
  • Ablation Techniques
  • Embolization Techniques
  • 6.2. Global Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Invasive Treatment
  • Minimally Invasive Treatment
  • Non-Invasive Treatment
  • 6.3. Global Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Center
  • 6.4. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Surgical Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Open Surgery
  • Myomectomy
  • 6.5. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Laparoscopic Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laparoscopic Myomectomy
  • Laparoscopic Hysterectomy
  • 6.6. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Ablation Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • 6.7. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Embolization Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Arterial Embolization (TAE)
  • Uterine Artery Embolization (UAE)

7. Uterine Fibroid Embolization Device Market Regional And Country Analysis

  • 7.1. Global Uterine Fibroid Embolization Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Uterine Fibroid Embolization Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Uterine Fibroid Embolization Device Market

  • 8.1. Asia-Pacific Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Uterine Fibroid Embolization Device Market

  • 9.1. China Uterine Fibroid Embolization Device Market Overview
  • 9.2. China Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Uterine Fibroid Embolization Device Market

  • 10.1. India Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Uterine Fibroid Embolization Device Market

  • 11.1. Japan Uterine Fibroid Embolization Device Market Overview
  • 11.2. Japan Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Uterine Fibroid Embolization Device Market

  • 12.1. Australia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Uterine Fibroid Embolization Device Market

  • 13.1. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Uterine Fibroid Embolization Device Market

  • 14.1. South Korea Uterine Fibroid Embolization Device Market Overview
  • 14.2. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Uterine Fibroid Embolization Device Market

  • 15.1. Western Europe Uterine Fibroid Embolization Device Market Overview
  • 15.2. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Uterine Fibroid Embolization Device Market

  • 16.1. UK Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Uterine Fibroid Embolization Device Market

  • 17.1. Germany Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Uterine Fibroid Embolization Device Market

  • 18.1. France Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Uterine Fibroid Embolization Device Market

  • 19.1. Italy Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Uterine Fibroid Embolization Device Market

  • 20.1. Spain Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Uterine Fibroid Embolization Device Market

  • 21.1. Eastern Europe Uterine Fibroid Embolization Device Market Overview
  • 21.2. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Uterine Fibroid Embolization Device Market

  • 22.1. Russia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Uterine Fibroid Embolization Device Market

  • 23.1. North America Uterine Fibroid Embolization Device Market Overview
  • 23.2. North America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Uterine Fibroid Embolization Device Market

  • 24.1. USA Uterine Fibroid Embolization Device Market Overview
  • 24.2. USA Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Uterine Fibroid Embolization Device Market

  • 25.1. Canada Uterine Fibroid Embolization Device Market Overview
  • 25.2. Canada Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Uterine Fibroid Embolization Device Market

  • 26.1. South America Uterine Fibroid Embolization Device Market Overview
  • 26.2. South America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Uterine Fibroid Embolization Device Market

  • 27.1. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Uterine Fibroid Embolization Device Market

  • 28.1. Middle East Uterine Fibroid Embolization Device Market Overview
  • 28.2. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Uterine Fibroid Embolization Device Market

  • 29.1. Africa Uterine Fibroid Embolization Device Market Overview
  • 29.2. Africa Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Uterine Fibroid Embolization Device Market Competitive Landscape And Company Profiles

  • 30.1. Uterine Fibroid Embolization Device Market Competitive Landscape
  • 30.2. Uterine Fibroid Embolization Device Market Company Profiles
    • 30.2.1. Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Uterine Fibroid Embolization Device Market Other Major And Innovative Companies

  • 31.1. Stryker Corporation
  • 31.2. Boston Scientific Corporation
  • 31.3. GE HealthCare Technologies Inc.
  • 31.4. Olympus Corporation
  • 31.5. Terumo Corporation
  • 31.6. Smith and Nephew plc.
  • 31.7. Ethicon Inc.
  • 31.8. Hologic Inc.
  • 31.9. CooperSurgical Inc.
  • 31.10. Ferring B.V.
  • 31.11. Cook Medical Inc.
  • 31.12. Karl Storz GmbH
  • 31.13. Merit Medical Systems
  • 31.14. CONMED Corporation
  • 31.15. Amsino International Inc.

32. Global Uterine Fibroid Embolization Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Uterine Fibroid Embolization Device Market

34. Recent Developments In The Uterine Fibroid Embolization Device Market

35. Uterine Fibroid Embolization Device Market High Potential Countries, Segments and Strategies

  • 35.1 Uterine Fibroid Embolization Device Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Uterine Fibroid Embolization Device Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Uterine Fibroid Embolization Device Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer